Please use symbol entry at top right of page to search

Pneumonia Testing Market to Reach $3.0 Bn, Globally, by 2030 at 6.5% CAGR: Allied Market Research

Increase in adoption of point of care (POC) testing and development in the field of nucleic acid detection across the world drive the growth of the global pneumonia testing market.

PORTLAND, Ore., May 16, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Pneumonia Testing Market by Types (Consumables, Analyzers), by Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), by Technology (Enzyme Linked Immunosorbant Assay, Immunofluoroscence, Western Blot, Polymerase Chain Reaction, Imunohistochemistry, Others), by End User (Hospitals, Diagnostic Laboratories, Homecare, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global pneumonia testing industry was estimated at $1.6 billion in 2020, and is anticipated to hit $3.0 billion by 2030, registering a CAGR of 6.5% from 2021 to 2030.

Allied_Market_Research_Logo

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/3776

Drivers, restraints, and opportunities-

Increase in adoption of point of care (POC) testing and development in the field of nucleic acid detection across the world drive the growth of the global pneumonia testing market. On the other hand, cultures, the traditional method, are still mostly used to detect pneumonia causative organisms, which hampers the growth to some extent. However, rise in healthcare expenditure, presence of advanced healthcare infrastructure, and availability of reimbursements are anticipated to create lucrative opportunities in the industry.

Covid-19 scenario-

  • Individuals suffering from Covid-19 are highly susceptible to pneumonia, and this factor impacted the global pneumonia testing market positively.
  • Rise in R&D activities related to the treatment of Covid-19 associated pneumonia boosted the market growth yet more.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/3776

The analyzers segment to dominate by 2030-

Based on types, the analyzers segment accounted for more than two-thirds of the global pneumonia testing market share in 2020, and is anticipated to rule the roost by 2030. Increase in the prevalence of pneumonia across the world drives the growth of the segment. The consumables segment, however, would cite the fastest CAGR of 7.0% throughout the forecast period, due to frequent usage of pneumonia tests.

The Point of Care testing segment to maintain the lion's share-

Based on method, the point of care testing segment held nearly three-fifths of the global pneumonia testing market revenue in 2020, and is expected to lead the trail by 2030. The same segment would also manifest the fastest CAGR of 6.9% from 2021 to 2030. Increase in the geriatric population, sedentary lifestyles, unhealthy food habits, and several environmental factors propel the segment growth.

North America garnered the major share in 2020-

Based on region, North America, held the major share in 2020, generating around two-fifths of the global pneumonia testing market. Prevalence of chronic diseases and emergence of advanced healthcare infrastructure across the region fuel the market growth. At the same time, the market across Asia-Pacific would grow at the fastest CAGR of 7.5% by 2030, due to rise in the geriatric population suffering from infectious diseases in the province.

Key players in the industry-

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • F-Hoffmann la Roche Ltd.
  • Hologic Inc.
  • BioMerieux
  • Becton
  • Quidel
  • Dickenson and Company
  • Meridian Biosciences
  • Quest Diagnostics
  • Bio-Rad Laboratories Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Artificial Intelligence for Drug Discovery and Development Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Laboratory Equipment and Disposables Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Cell Therapy Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Digital Diabetes Management Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Disposable Syringes Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

VR In Healthcare Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Gene Panel Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Spirometer Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Muscle Stimulator Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Fertility Test Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Cision View original content:https://www.prnewswire.com/news-releases/pneumonia-testing-market-to-reach-3-0-bn-globally-by-2030-at-6-5-cagr-allied-market-research-301547676.html

SOURCE Allied Market Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.